Skip to main content

Table 4 Selected predictor valiables for multivariable model of severe PHLF in patients with HCC

From: Impact of aspartate aminotransferase–to–platelet ratio index based score to assess posthepatectomy liver failure in patients with hepatocellular carcninoma

Variables No. of risk point for severe PHLF Odds ratio (95% CI) P value
APRI    0.0070*
 < 1.56 0 1 [Reference]  
 ≥ 1.56 1 5.17 (2.00–13.4)  
MELD score    0.0001**
 < 8.3 0 1 [Reference]  
 ≥ 8.3 1 9.11 (2.94–28.2)  
Operating time (min)    < 0.0001**
 < 407 0 1 [Reference]  
 ≥ 407 1 16.8 (4.20–67.3)  
Intraoperative blood loss (mL)    0.0056*
 < 847 0 1 [Reference]  
 ≥ 847 1 3.92 (1.49–10.3)  
  1. APRI AST-to-platelet ratio index, AST asparate aminotransferase, CI confidence interval, MELD model for end-stage liver disease, PHLF posthepatectomy liver failure *P < 0.05 and **P < 0.001